|
NO760996L
(enExample)
|
1975-03-25 |
1976-09-28 |
Byk Gulden Lomberg Chem Fab |
|
|
US4072746A
(en)
|
1975-10-14 |
1978-02-07 |
Sterling Drug Inc. |
3-Amino-5-(pyridinyl)-2(1H)-pyridinones
|
|
US4004012A
(en)
|
1975-10-14 |
1977-01-18 |
Sterling Drug Inc. |
3-Cyano-5-(pyridinyl)-2(1H)-pyridinones
|
|
DE2845456A1
(de)
|
1978-10-19 |
1980-08-14 |
Merck Patent Gmbh |
6-arylpyridazin-3-one und verfahren zu ihrer herstellung
|
|
US4298609A
(en)
|
1979-08-30 |
1981-11-03 |
Sterling Drug Inc. |
4,5-Dihydro-6-(4-pyridinyl)-3-pyridazinol and salts, their preparation and use as blood pressure lowering agents
|
|
FR2478640A1
(fr)
|
1980-03-24 |
1981-09-25 |
Sanofi Sa |
Nouvelles thieno (2,3-d) pyridazinones-4 et thieno (2,3-d) pyridazinones-7, leur procede de preparation et leur therapeutique
|
|
US4337253A
(en)
|
1980-04-28 |
1982-06-29 |
Sterling Drug Inc. |
4,5-Dihydro-2-methyl-6-(4-pyridinyl)-3(2H)-pyridazinone and its use as a cardiotonic
|
|
US4305943A
(en)
|
1980-04-28 |
1981-12-15 |
Sterling Drug Inc. |
4-Amino-6-(pyridinyl)-3(2H)-pyridazinones and their use as cardiotonics
|
|
US4304776A
(en)
|
1980-04-28 |
1981-12-08 |
Sterling Drug Inc. |
4-Substituted-6-(pyridinyl)-3(2h)-pyridazinones and their use as intermediates and cardiotonics
|
|
US4486431A
(en)
|
1981-01-14 |
1984-12-04 |
Sterling Drug Inc. |
Cardiotonic use of 4,5-dihydro-6-(4-pyridinyl)-3(2H)-pyridazinones
|
|
US4338446A
(en)
|
1980-04-28 |
1982-07-06 |
Sterling Drug Inc. |
Di-(lower-alkyl)hydroxy-[2-oxo-2-(pyridinyl)ethyl]-propanedioates
|
|
US4346221A
(en)
|
1980-04-28 |
1982-08-24 |
Sterling Drug Inc. |
Preparation of 4-amino-6-(pyridinyl)-3(2H)-pyridazinones from 6-(pyridinyl)-3(2H)-pyridazinones
|
|
US4559352A
(en)
|
1981-03-30 |
1985-12-17 |
Sterling Drug Inc. |
1,2-Dihydro-2-oxo-5-(hydroxy-and/or amino-phenyl)-nicotinonitriles and cardiotonic use thereof
|
|
US4404203A
(en)
|
1981-05-14 |
1983-09-13 |
Warner-Lambert Company |
Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
|
|
US4397854A
(en)
|
1981-05-14 |
1983-08-09 |
Warner-Lambert Company |
Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
|
|
US4515797A
(en)
|
1981-09-08 |
1985-05-07 |
Sterling Drug Inc. |
3-Amino-5-(hydroxy- and/or aminophenyl)-6-(lower-alkyl)-2(1H)-pyridinones and cardiotonic use thereof
|
|
US4465686A
(en)
|
1981-09-08 |
1984-08-14 |
Sterling Drug Inc. |
5-(Hydroxy- and/or amino-phenyl)-6-(lower-alkyl)-2-(1H)-pyridinones, their cardiotonic use and preparation
|
|
US4353905A
(en)
|
1981-09-17 |
1982-10-12 |
Warner-Lambert Company |
Substituted 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and 6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones
|
|
US4599423A
(en)
|
1982-04-26 |
1986-07-08 |
Sterling Drug Inc. |
Preparation of 5-(hydroxy- and/or aminophenyl-6-lower-alkyl)-2(1H)-pyridinones
|
|
US4734415A
(en)
|
1982-08-13 |
1988-03-29 |
Warner-Lambert Company |
Substituted 4,5-dihydro-6-(substituted)-phenyl-3(2H)-pyridazinones and 6-(substituted) phenyl-3(2H)-pyridazinones
|
|
DE3241102A1
(de)
|
1982-11-06 |
1984-05-10 |
A. Nattermann & Cie GmbH, 5000 Köln |
Imidazolylalkylthienyl-tetrahydropyridazine und verfahren zu ihrer herstellung
|
|
DE3321012A1
(de)
|
1983-06-10 |
1984-12-13 |
A. Nattermann & Cie GmbH, 5000 Köln |
Substituierte 4,5-dihydro-6-(thien-2-yl)-3(2h)-pyridazinone und 6-(thien-2-yl)-3(2h)-pyridazinone sowie verfahren zu ihrer herstellung
|
|
US4666902A
(en)
|
1983-06-20 |
1987-05-19 |
Cassella Aktiengesellschaft |
Tetrahydropyridazinone derivatives, processes for their preparation and their use
|
|
GB8323553D0
(en)
|
1983-09-02 |
1983-10-05 |
Smith Kline French Lab |
Pharmaceutical compositions
|
|
US4816454A
(en)
|
1984-09-21 |
1989-03-28 |
Cassella Aktiengesellschaft |
4,5-dihydro-3(2H)-pyridazinones and their pharmacological use
|
|
US5112625A
(en)
|
1989-02-15 |
1992-05-12 |
Wm. Wrigley Jr. Company |
Aqueous zein coated sweeteners and other ingredients for chewing gum
|
|
US5217735A
(en)
|
1986-10-22 |
1993-06-08 |
Wm. Wrigley Jr. Company |
Method of making chewing gum with delayed release ingredients
|
|
US5221543A
(en)
|
1986-10-22 |
1993-06-22 |
Firma Wilhelm Fette Gmbh |
Method of making a fast release stabilized aspartame ingredient for chewing gum
|
|
US4863745A
(en)
|
1986-10-22 |
1989-09-05 |
Wm. Wrigley Jr. Company |
Chewing gum containing zein coated high-potency sweetener and method
|
|
US5192563A
(en)
|
1986-10-22 |
1993-03-09 |
Wm. Wrigley, Jr. Company |
Strongly mint-flavored chewing gums with reduced bitterness and harshness
|
|
US4908371A
(en)
|
1987-11-10 |
1990-03-13 |
Ciba-Geigy Corporation |
Esterified hydroxy dihydropyridinones for treating diseases associated with trivalent metal ion overload
|
|
US4919941A
(en)
|
1987-12-18 |
1990-04-24 |
Wm. Wrigley Jr. Company |
Chewing gum containing delayed release protein sweetener and method
|
|
DE4134467A1
(de)
|
1991-10-18 |
1993-04-22 |
Thomae Gmbh Dr K |
Heterobiarylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
|
JP3120857B2
(ja)
|
1990-02-19 |
2000-12-25 |
中外製薬株式会社 |
新規な縮合複素環化合物とこれを用いた抗喘息剤
|
|
DE4023369A1
(de)
|
1990-07-23 |
1992-01-30 |
Thomae Gmbh Dr K |
Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
|
ATE180475T1
(de)
|
1990-09-21 |
1999-06-15 |
Rohm & Haas |
Dihydropyridazinone und pyridazinone als fungizide
|
|
WO1992006087A1
(en)
|
1990-10-02 |
1992-04-16 |
Kaken Pharmaceutical Co., Ltd. |
Pyridazinone-substituted ethynylphenyl derivative and remedy for circulatory organ disease containing the same as active ingredient
|
|
DE4127404A1
(de)
|
1991-08-19 |
1993-02-25 |
Thomae Gmbh Dr K |
Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
|
CN1038249C
(zh)
|
1991-08-28 |
1998-05-06 |
罗姆和哈斯公司 |
含有二氢哒嗪酮及其相关化合物的杀菌组合物
|
|
US5716954A
(en)
|
1991-10-09 |
1998-02-10 |
Syntex U.S.A. Inc. |
Benzopyridazinone and pyridopyridazinone compounds
|
|
IL103388A
(en)
|
1991-10-09 |
1997-09-30 |
Syntex Inc |
PYRIDO £2,3-d| PYRIDAZINONES AND PYRIDAZINETHIONES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
|
|
DE4237656A1
(de)
|
1992-06-13 |
1993-12-16 |
Merck Patent Gmbh |
Benzimidazolderivate
|
|
US5668279A
(en)
|
1992-11-02 |
1997-09-16 |
Merck & Co., Inc. |
Substituted phthalazinones as neurotensin antagonists
|
|
US5814651A
(en)
|
1992-12-02 |
1998-09-29 |
Pfizer Inc. |
Catechol diethers as selective PDEIV inhibitors
|
|
EP0634404A1
(en)
|
1993-07-13 |
1995-01-18 |
Rhone Poulenc Agriculture Ltd. |
Phtalazin derivatives and their use as pesticides
|
|
GB9314412D0
(en)
|
1993-07-13 |
1993-08-25 |
Rhone Poulenc Agriculture |
New compositions of matter
|
|
TW263498B
(enExample)
|
1993-11-10 |
1995-11-21 |
Takeda Pharm Industry Co Ltd |
|
|
JP3247540B2
(ja)
|
1994-05-12 |
2002-01-15 |
株式会社日立製作所 |
パケット化通信装置および切替え装置
|
|
US5466697A
(en)
|
1994-07-13 |
1995-11-14 |
Syntex (U.S.A.) Inc. |
8-phenyl-1,6-naphthyridin-5-ones
|
|
IL115889A0
(en)
|
1994-11-14 |
1996-01-31 |
Rohm & Haas |
Pyridazinones and their use as fungicides
|
|
JPH08337583A
(ja)
|
1995-04-13 |
1996-12-24 |
Takeda Chem Ind Ltd |
複素環化合物およびその製造法
|
|
US5635494A
(en)
|
1995-04-21 |
1997-06-03 |
Rohm And Haas Company |
Dihydropyridazinones and pyridazinones and their use as fungicides and insecticides
|
|
WO1997001551A1
(en)
|
1995-06-26 |
1997-01-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Pyrazole compounds and pharmaceutical compositions
|
|
IL118631A
(en)
|
1995-06-27 |
2002-05-23 |
Tanabe Seiyaku Co |
History of pyridazinone and processes for their preparation
|
|
AU723064B2
(en)
|
1995-08-25 |
2000-08-17 |
Dow Agrosciences Llc |
Compositions having synergistic fungitoxic effects
|
|
DE69717160T2
(de)
|
1996-09-13 |
2003-05-08 |
Mitsubishi Pharma Corp., Osaka |
Thienotriazolodiazepinverbindungen und ihre medizinischen anwendungen
|
|
US5855654A
(en)
|
1997-01-30 |
1999-01-05 |
Rohm And Haas Company |
Pyridazinones as marine antifouling agents
|
|
PT984961E
(pt)
|
1997-04-01 |
2001-11-30 |
Astrazeneca Ab |
Novos derivados de piridina e composicoes farmaceuticas que os contem
|
|
US6245804B1
(en)
|
1997-05-30 |
2001-06-12 |
Schering Aktiengesellschaft |
Nonsteroidal gestagens
|
|
US6307047B1
(en)
|
1997-08-22 |
2001-10-23 |
Abbott Laboratories |
Prostaglandin endoperoxide H synthase biosynthesis inhibitors
|
|
KR100626605B1
(ko)
|
1997-11-19 |
2006-09-22 |
코와 가부시키가이샤 |
신규 피리다진 유도체 및 이를 유효성분으로 하는 의약
|
|
EP1036076B1
(en)
|
1997-12-05 |
2002-09-04 |
AstraZeneca UK Limited |
Novel compounds
|
|
EP0934933A1
(en)
|
1998-02-06 |
1999-08-11 |
Byk Gulden Lomberg Chemische Fabrik GmbH |
Phthalazinones
|
|
TWI241295B
(en)
|
1998-03-02 |
2005-10-11 |
Kowa Co |
Pyridazine derivative and medicine containing the same as effect component
|
|
KR20010071936A
(ko)
|
1998-07-16 |
2001-07-31 |
시오노 요시히코 |
항종양 활성을 갖는 피리미딘 유도체
|
|
US6271380B1
(en)
|
1998-12-30 |
2001-08-07 |
Dupont Pharmaceuticals Company |
1H-imidazo[4,5-d]pyridazin-7-ones, 3H-imidazo-[4,5-c]pyridin-4-ones and corresponding thiones as corticotropin releasing factor (CRF) receptor ligands
|
|
CN1297916A
(zh)
|
1999-11-26 |
2001-06-06 |
上海博容基因开发有限公司 |
一种新的多肽——人含溴基结构域的蛋白95和编码这种多肽的多核苷酸
|
|
DE10010423A1
(de)
|
2000-03-03 |
2001-09-06 |
Bayer Ag |
Substituierte 2,5-Dimethyldihydropyridazinone und ihre Verwendung
|
|
CN1315397A
(zh)
|
2000-03-28 |
2001-10-03 |
上海博德基因开发有限公司 |
一种新的多肽——人溴基结构域10和编码这种多肽的多核苷酸
|
|
AU2000256968B2
(en)
|
2000-07-04 |
2006-03-16 |
Robert John Eyre |
Harvesting machine
|
|
US20030114448A1
(en)
|
2001-05-31 |
2003-06-19 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of factor Xa
|
|
JP2003313169A
(ja)
|
2002-04-19 |
2003-11-06 |
Otsuka Chemical Holdings Co Ltd |
４，４−ジフルオロ−３−ブテニル化合物及び農園芸用殺虫・殺ダニ剤
|
|
ES2195785B1
(es)
|
2002-05-16 |
2005-03-16 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de piridazin-3(2h)-ona.
|
|
WO2004014892A1
(en)
|
2002-08-13 |
2004-02-19 |
Warner-Lambert Company Llc |
Monocyclic derivatives as matrix metalloproteinase inhibitors
|
|
WO2004014384A2
(en)
|
2002-08-13 |
2004-02-19 |
Warner-Lambert Company Llc |
Cyclic compounds containing zinc binding groups as matrix metalloproteinase inhibitors
|
|
WO2005007644A1
(ja)
|
2003-06-27 |
2005-01-27 |
Banyu Pharmaceutical Co., Ltd |
ヘテロアリールオキシ含窒素飽和へテロ環誘導体
|
|
WO2005000818A1
(en)
|
2003-06-27 |
2005-01-06 |
Warner-Lambert Company Llc |
5-substituted-4-`(substituted phenyl)!amino!-2-pyridone deviatives for use as mek inhibitors
|
|
US7226920B2
(en)
|
2003-08-06 |
2007-06-05 |
Vertex Pharmaceuticals Inc. |
Aminotriazole compounds useful as inhibitors of protein kinases
|
|
AR045595A1
(es)
*
|
2003-09-04 |
2005-11-02 |
Vertex Pharma |
Composiciones utiles como inhibidores de proteinas quinasas
|
|
CN1870896A
(zh)
|
2003-10-20 |
2006-11-29 |
默克公司 |
用作hiv整合酶抑制剂的羟基吡啶并吡咯并吡嗪二酮化合物
|
|
US7223733B2
(en)
|
2004-03-31 |
2007-05-29 |
National University Of Singapore |
Modulation of TRIP-Br function and method of treating proliferative disorders
|
|
US7662832B2
(en)
*
|
2004-09-03 |
2010-02-16 |
Yuhan Corporation |
Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof
|
|
GB0420970D0
(en)
|
2004-09-21 |
2004-10-20 |
Smithkline Beecham Corp |
Novel triazoloquinoline compounds
|
|
WO2006038734A1
(en)
|
2004-10-08 |
2006-04-13 |
Astellas Pharma Inc. |
Pyridazinone derivatives cytokines inhibitors
|
|
US20080090827A1
(en)
|
2004-11-30 |
2008-04-17 |
Artesian Therapeutics, Inc. |
Compounds With Mixed Pde-Inhibitory and Beta-Adrenergic Antagonist or Partial Agonist Activity For Treatment of Heart Failure
|
|
US8158652B2
(en)
|
2004-12-01 |
2012-04-17 |
Msd K.K. |
Substituted pyridone derivative
|
|
AU2006223236A1
(en)
|
2005-03-14 |
2006-09-21 |
Merck Sharp & Dohme Corp. |
CGRP receptor antagonists
|
|
US20060276496A1
(en)
|
2005-03-17 |
2006-12-07 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Anti-Cytokine Heterocyclic Compounds
|
|
WO2006112331A1
(ja)
|
2005-04-13 |
2006-10-26 |
Dainippon Simitomo Pharma Co., Ltd. |
新規縮合ピロール誘導体
|
|
JP5159305B2
(ja)
|
2005-05-30 |
2013-03-06 |
田辺三菱製薬株式会社 |
チエノトリアゾロジアゼピン化合物及びその医薬としての用途
|
|
WO2007008144A1
(en)
|
2005-07-08 |
2007-01-18 |
Astrazeneca Ab |
Heterocyclic sulfonamide derivatives as inhibitors of factor xa
|
|
WO2007008145A1
(en)
|
2005-07-08 |
2007-01-18 |
Astrazeneca Ab |
Heterocyclic sulfonamide derivatives as inhibitors of factor xa
|
|
AU2006306991A1
(en)
|
2005-10-28 |
2007-05-03 |
Takeda Pharmaceutical Company Limited |
Heterocyclic amide compound and use thereof
|
|
US8163749B2
(en)
|
2005-12-14 |
2012-04-24 |
Bristol-Myers Squibb Company |
Six-membered heterocycles useful as serine protease inhibitors
|
|
US20070142414A1
(en)
|
2005-12-16 |
2007-06-21 |
Pharmacia Italia S.P.A. |
N-substituted pyrrolopyridinones active as kinase inhibitors
|
|
NZ574873A
(en)
|
2006-07-25 |
2012-03-30 |
Cephalon Inc |
Pyridazinone derivatives as h3 inhibitors
|
|
WO2008024978A2
(en)
|
2006-08-24 |
2008-02-28 |
Serenex, Inc. |
Tetrahydroindolone and tetrahydroindazolone derivatives
|
|
US7838523B2
(en)
|
2006-09-11 |
2010-11-23 |
Cgi Pharmaceuticals, Inc. |
Certain substituted amides, method of making, and method of use thereof
|
|
EP2097422A4
(en)
|
2006-11-13 |
2010-04-14 |
Lilly Co Eli |
THIENOPYRIMIDINONE FOR THE TREATMENT OF INFLAMMATORY DISEASES AND CARCINOMAS
|
|
NZ577208A
(en)
|
2006-12-14 |
2012-06-29 |
Gilead Sciences Inc |
Viral inhibitors
|
|
JP2008156311A
(ja)
|
2006-12-26 |
2008-07-10 |
Institute Of Physical & Chemical Research |
Ｂｒｄ２ブロモドメイン結合剤
|
|
US20080312307A1
(en)
|
2007-05-25 |
2008-12-18 |
Takeda Pharmaceutical Company Limited |
Mapk/erk kinase inhibitors
|
|
WO2009017671A1
(en)
|
2007-07-26 |
2009-02-05 |
Vitae Pharmaceuticals, Inc. |
Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
|
|
CL2008002793A1
(es)
|
2007-09-20 |
2009-09-04 |
Cgi Pharmaceuticals Inc |
Compuestos derivados de amidas sustituidas, inhibidores de la actividad de btk; composicion farmaceutica que los comprende; utiles en el tratamiento del cancer, trastornos oseos, enfermedades autoinmunes, entre otras
|
|
JP5587193B2
(ja)
|
2007-10-23 |
2014-09-10 |
エフ．ホフマン−ラ ロシュ アーゲー |
新規なキナーゼ阻害剤
|
|
WO2009054790A1
(en)
|
2007-10-26 |
2009-04-30 |
Astrazeneca Ab |
Amide linked heteroaromatic derivatives as modulators of mglur5
|
|
AU2008345225A1
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
KR101600634B1
(ko)
|
2007-12-28 |
2016-03-07 |
미쓰비시 타나베 파마 코퍼레이션 |
항암제
|
|
US20100137320A1
(en)
|
2008-02-29 |
2010-06-03 |
Schering Corporation |
Gamma secretase modulators
|
|
JP5301563B2
(ja)
|
2008-05-01 |
2013-09-25 |
ヴァイティー ファーマシューティカルズ，インコーポレイテッド |
１１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状インヒビター
|
|
EP2291373B1
(en)
|
2008-05-01 |
2013-09-11 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
CA2723034A1
(en)
|
2008-05-01 |
2009-11-05 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
WO2009142732A2
(en)
|
2008-05-20 |
2009-11-26 |
Cephalon, Inc. |
Substituted pyridazinone derivatives as histamine-3 (h3) receptor ligands
|
|
PL2324018T3
(pl)
|
2008-07-25 |
2014-02-28 |
Boehringer Ingelheim Int |
Cykliczne inhibitory dehydrogenazy 11 beta-hydroksysteroidowej typu 1
|
|
CA2737219C
(en)
|
2008-08-11 |
2017-02-28 |
Tracy Keller |
Halofuginone analogs for inhibition of trna synthetases and uses thereof
|
|
JP5102397B2
(ja)
|
2008-11-20 |
2012-12-19 |
メルク・シャープ・エンド・ドーム・コーポレイション |
アリールメチルベンゾキナゾリノンｍ１レセプターポジティブアロステリックモジュレーター
|
|
EP2196465A1
(en)
|
2008-12-15 |
2010-06-16 |
Almirall, S.A. |
(3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
|
|
KR20120061771A
(ko)
|
2009-04-30 |
2012-06-13 |
비타이 파마슈티컬즈, 인코포레이티드 |
11베타-하이드록시스테로이드 탈수소효소 1의 고리형 억제제
|
|
GB0919426D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
ES2652304T3
(es)
|
2009-11-05 |
2018-02-01 |
Glaxosmithkline Llc |
Compuesto de benzodiacepina novedoso
|
|
US9360482B2
(en)
|
2009-11-05 |
2016-06-07 |
Glaxosmithkline Llc |
Process for the identification of a compound which inhibits the binding of the second bromodomain of each of human BRD-2, BRD-3, and BRD-4
|
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
|
GB0919434D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
US9102677B2
(en)
|
2009-11-05 |
2015-08-11 |
Glaxosmithkline Llc |
Benzodiazepine bromodomain inhibitor
|
|
GB0919423D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
WO2011060067A2
(en)
|
2009-11-11 |
2011-05-19 |
E. I. Du Pont De Nemours And Company |
Refrigerant storage in secondary loop refrigeration systems
|
|
US8927561B2
(en)
|
2010-04-23 |
2015-01-06 |
Kineta, Inc. |
Pyrimidinedione anti-viral compounds
|
|
EP2902030B1
(en)
|
2010-05-14 |
2016-09-14 |
Dana-Farber Cancer Institute, Inc. |
Thienotriazolodiazepine compounds for treating neoplasia
|
|
JP5844358B2
(ja)
|
2010-06-22 |
2016-01-13 |
グラクソスミスクライン エルエルシー |
ベンゾトリアゾロジアゼピン化合物を含むブロモドメイン阻害剤
|
|
US9249161B2
(en)
|
2010-12-02 |
2016-02-02 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
JP2015505087A
(ja)
|
2011-12-07 |
2015-02-16 |
アフェクティヴァ, インコーポレイテッドAffectiva, Inc. |
広告効果の感情に基づく評価
|
|
WO2013097052A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbott Laboratories |
Bromodomain inhibitors
|
|
US20130188311A1
(en)
|
2012-01-23 |
2013-07-25 |
International Business Machines Corporation |
Cooling and noise-reduction apparatus
|
|
CA2870931A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Isoindolone derivatives
|
|
EP2858982A4
(en)
|
2012-06-12 |
2015-11-11 |
Abbvie Inc |
PYRIDINONE AND PYRIDAZINONE DERIVATIVES
|
|
CN104620223B
(zh)
|
2012-06-15 |
2018-11-16 |
英特尔公司 |
对于基于存储资历实现从不同线程进行转发的线程不可知的加载存储缓冲器
|
|
US20140094456A1
(en)
|
2012-10-02 |
2014-04-03 |
Intermune, Inc. |
Anti-fibrotic pyridinones
|
|
AR092742A1
(es)
|
2012-10-02 |
2015-04-29 |
Intermune Inc |
Piridinonas antifibroticas
|
|
WO2014125408A2
(en)
|
2013-02-12 |
2014-08-21 |
Aurigene Discovery Technologies Limited |
Substituted 1h-pyrrolopyridinone derivatives as kinase inhibitors
|
|
EP2970285B1
(en)
|
2013-03-11 |
2019-04-17 |
AbbVie Inc. |
Fused tetracyclic bromodomain inhibitors
|
|
JP2016512524A
(ja)
*
|
2013-03-11 |
2016-04-28 |
アッヴィ・インコーポレイテッド |
ブロモドメイン阻害剤
|
|
CN105164113B
(zh)
|
2013-03-12 |
2018-03-02 |
艾伯维公司 |
吡咯酰胺抑制剂
|
|
CN105026403B
(zh)
|
2013-03-12 |
2018-05-18 |
艾伯维公司 |
四环布罗莫结构域抑制剂
|
|
HK1218909A1
(zh)
|
2013-03-12 |
2017-03-17 |
Abbvie Inc. |
二氢-吡咯并吡啶酮布罗莫结构域抑制剂
|
|
AR096758A1
(es)
|
2013-06-28 |
2016-02-03 |
Abbvie Inc |
Inhibidores cristalinos de bromodominios
|
|
MX2015017963A
(es)
|
2013-06-28 |
2016-11-10 |
Abbvie Inc |
Inhibidores de bromodominio.
|
|
CN103387576A
(zh)
*
|
2013-08-09 |
2013-11-13 |
中国药科大学 |
基于嘌呤结构的芳酰胺类Raf激酶抑制剂及其制备方法和用途
|
|
EA035727B1
(ru)
*
|
2013-10-18 |
2020-07-31 |
Селджен Квонтисел Рисёрч, Инк. |
Ингибиторы бромодомена
|
|
US9399640B2
(en)
|
2013-11-26 |
2016-07-26 |
Incyte Corporation |
Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors
|
|
WO2015081246A1
(en)
|
2013-11-26 |
2015-06-04 |
Incyte Corporation |
Bicyclic heterocycles as bet protein inhibitors
|
|
WO2015081280A1
(en)
|
2013-11-26 |
2015-06-04 |
Coferon, Inc. |
Bromodomain ligands capable of dimerizing in an aqueous solution
|
|
WO2015081189A1
(en)
|
2013-11-26 |
2015-06-04 |
Incyte Corporation |
Bicyclic heterocycles as bet protein inhibitors
|
|
CN105939996A
(zh)
|
2013-12-09 |
2016-09-14 |
艾伯维公司 |
用作布罗莫结构域抑制剂的二氢吡啶酮和二氢哒嗪酮衍生物
|
|
US9994581B2
(en)
|
2013-12-10 |
2018-06-12 |
Abbvie Inc. |
Bromodomain inhibitors
|
|
SI3674302T1
(sl)
|
2014-04-23 |
2023-07-31 |
Incyte Holdings Corporation |
1h-pirolo(2,3-c)piridin-7(6h)-oni in pirazolo(3,4-c)piridin-7(6h)-oni kot zaviralci proteinov bet
|
|
MA40940A
(fr)
|
2014-11-10 |
2017-09-19 |
Constellation Pharmaceuticals Inc |
Pyrrolopyridines substituées utilisées en tant qu'inhibiteurs de bromodomaines
|
|
WO2016183114A1
(en)
|
2015-05-11 |
2016-11-17 |
Bristol-Myers Squibb Company |
Tricyclic compounds as anticancer agents
|
|
WO2016183115A1
(en)
|
2015-05-12 |
2016-11-17 |
Bristol-Myers Squibb Company |
5h-pyrido[3,2-b]indole compounds as anticancer agents
|
|
JP6606444B2
(ja)
|
2016-03-10 |
2019-11-13 |
株式会社Ｓｕｂａｒｕ |
車両用制御装置
|
|
LT3442947T
(lt)
|
2016-04-15 |
2023-09-11 |
Epizyme, Inc. |
Aminu pakeisti arilo arba heteroarilo junginiai, kaip ehmt1 ir ehmt2 inhibitoriai
|
|
WO2017178582A1
(en)
|
2016-04-15 |
2017-10-19 |
Syngenta Participations Ag |
Herbicidal pyridazinone compounds
|
|
FI3442977T3
(fi)
|
2016-04-15 |
2023-09-26 |
Blueprint Medicines Corp |
Aktiviinireseptorin kaltaisen kinaasin estäjät
|
|
ES2953467T3
(es)
|
2016-04-15 |
2023-11-13 |
Elanco Animal Health Gmbh |
Derivados de pirazolopirimidina
|
|
SG11201808003RA
(en)
*
|
2016-04-15 |
2018-10-30 |
Abbvie Inc |
Bromodomain inhibitors
|
|
EP3468559B1
(en)
|
2016-06-09 |
2023-11-22 |
Dana Farber Cancer Institute, Inc. |
Methods of use and pharmaceutical combinations of hdac inhibitors with bet inhibitors
|
|
WO2017216772A2
(en)
|
2016-06-16 |
2017-12-21 |
The University Of Chicago |
Methods and compositions for treating breast and prostate cancer
|
|
WO2017223268A1
(en)
|
2016-06-22 |
2017-12-28 |
Yale University |
COMPOSITIONS AND METHODS OF RESENSITIZING CELLS TO BROMODOMAIN AND EXTRATERMINAL DOMAIN PROTEIN INHIBITORS (BETi)
|
|
EP3526210A4
(en)
|
2016-10-14 |
2020-04-22 |
AbbVie Inc. |
BROMODOMAIN INHIBITORS
|
|
EP3800182A1
(en)
|
2016-10-14 |
2021-04-07 |
AbbVie Inc. |
Pyridin-2(1h)-one derivatives as bromodomain inhibitors
|
|
WO2018095933A1
(en)
|
2016-11-22 |
2018-05-31 |
Université D'aix-Marseille (Amu) |
Method of prognosticating, or for determining the efficiency of a compound for treating cancer
|
|
WO2018130174A1
(zh)
|
2017-01-11 |
2018-07-19 |
江苏豪森药业集团有限公司 |
吡咯并[2,3-c]吡啶类衍生物、其制备方法及其在医药上的应用
|
|
EP3609896A4
(en)
|
2017-04-14 |
2020-11-04 |
AbbVie Inc. |
BROMODOMAIN INHIBITORS
|
|
CN108976278B
(zh)
|
2017-06-05 |
2021-04-06 |
海创药业股份有限公司 |
一种嵌合分子及其制备和应用
|
|
CN108690020A
(zh)
|
2018-07-04 |
2018-10-23 |
清华大学 |
一种靶向降解bet蛋白的化合物及其应用
|